Cyclohexanecarboxylic Acid Synthesis via Nitrile Hydrolysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing cyclohexanecarboxylic acid derivatives are inefficient and lack specificity for producing pharmaceutically active compounds, particularly in the synthesis of intermediates like 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid.

Innovation Solution

A process involving the hydrolysis of cyclohexanecarbonitrile derivatives with strong acids or aqueous bases, followed by nitrosylation and subsequent reactions with halogenating agents, triphenylphosphine, and acylation steps to produce cyclohexanecarboxylic acid derivatives, allowing for the extraction and purification of the desired compounds.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current methods are used for preparing cyclohexanecarboxylic acid derivatives, then the synthesis can be performed with existing procedures, but the efficiency and specificity for producing pharmaceutically active compounds are insufficient

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidspecificity for pharmaceutically active compounds
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The synthesis process is divided into distinct sequential steps: hydrolysis of nitrile to amide, conversion to acid, and nitrosylation to form the final derivative. Each step is optimized independently with specific reagents and conditions, allowing for better control and efficiency at each stage while maintaining high specificity for the desired pharmaceutical intermediate.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs specific parameter optimizations including temperature control during hydrolysis, pH adjustment during extraction, and stoichiometric ratios of reagents in nitrosylation. These parameter changes enable improved reaction efficiency and specificity, transforming a generic synthesis approach into a optimized process for pharmaceutically active compounds.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If multiple reaction steps are performed to synthesize cyclohexanecarboxylic acid derivatives, then the desired compound can be produced, but the process complexity increases

Engineering Contradiction:
Improveyield of desired compoundVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent combines the hydrolysis and nitrosylation steps in a integrated process flow where the output of one step directly feeds into the next without requiring separate isolation and purification intermediates. This merging of steps maintains high yield while reducing overall process complexity compared to performing each reaction separately with full workup between steps.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nitrile group is converted to the amide intermediate first, preparing the molecule in advance for the subsequent nitrosylation reaction. This preliminary action optimizes the molecular structure before the key transformation, enabling higher final yield while organizing the process in a logical sequence that manages complexity.

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If extraction and purification steps are performed to isolate the desired compound, then the purity of the product is improved, but the time and resources required increase

Engineering Contradiction:
Improvepurity of productVSAvoidpurification time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent utilizes acid-base phase transitions for extraction and purification. The compound is converted to its salt form for aqueous extraction, then regenerated to the free form for isolation. This phase transition approach achieves high purity through selective solubility differences while minimizing time compared to chromatographic or repeated crystallization methods.

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The patent uses pH adjustment as an intermediary mechanism to control the solubility and phase distribution of the compound during extraction. By mediating the extraction process through pH control, high purity is achieved with minimal steps and reduced time investment compared to direct extraction methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process effectively synthesizes cyclohexanecarboxylic acid derivatives, enabling their use as valuable intermediates in pharmaceutical synthesis with improved yields and specificity, as demonstrated by the production of 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid.

Implementation Method 1

reacting with H2O in the presence of a strong acid or with an aqueous base to obtain a cyclohexanecarboxylic acid amide derivative

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

reacting the said cyclohexanecarboxylic acid amide derivative with a nitrosylating agent, to obtain the compound of formula (I)

Methodology Applied
Scientific EffectNitrosylation: Oxidation

Implementation Method 3

solution extracting the compound of formula (I) preferably out of an organic solvent by adjusting the solution to a basic pH, preferably of pH of 9 to 14

Methodology Applied
Scientific EffectLiquid-liquid extraction: Liquid-Liquid Extraction

Data Source

PatentEP2274264B1New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative
Publication Date: 2014.02.12 F HOFFMANN LA ROCHE & CO AG
  • EP2274264B1 patent drawing
  • EP2274264B1 patent drawing
  • EP2274264B1 patent drawing

AI summary

A process for the preparation of a compound of Formula (I): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.